CRISPR Therapeutics (CRSP) Names Michael Tomsicek as CFO – StreetInsider.com
|
CRISPR Therapeutics (CRSP) Names Michael Tomsicek as CFO
StreetInsider.com CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announces the appointment of Michael Tomsicek as Chief Financial Officer. Mr. Tomsicek is a highly … Equities Analysts Offer Predictions for Crispr Theraptc's FY2017 Earnings (CRSP) Head to Head Analysis: Crispr Theraptc (CRSP) versus The Competition Crispr Theraptc (CRSP) Receives Hold Rating from SunTrust Banks, Inc. |
